thalidomide
Showing 26 - 50 of 271
Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)
Active, not recruiting
- Myeloma
- Melphalan
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Dec 1, 2021
HIV, Stomatitis, Aphthous Trial in Puerto Rico, United States (Thalidomide)
Completed
- HIV Infections
- Stomatitis, Aphthous
- Thalidomide
-
Birmingham, Alabama
- +39 more
Oct 27, 2021
Tumors Metastatic to Brain Trial in Philadelphia (radiation, drug, procedure)
Completed
- Tumors Metastatic to Brain
- radiation therapy
- +2 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)
Recruiting
- Glioma
- +6 more
- Metronomic Cyclophosphamide
- Thalidomide
-
Saint Louis, MissouriWashington University School of Medicine
Sep 22, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Dexamethasone
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2020
Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)
Active, not recruiting
- Multiple Myeloma
- Velcade
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Sep 7, 2021
Immunoglobulin Light-Chain Amyloidosis Trial in Guangzhou (Thalidomide, Cyclophosphamide)
Recruiting
- Immunoglobulin Light-Chain Amyloidosis
- Thalidomide
- Cyclophosphamide
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People'S Hospital
Oct 27, 2020
Melanoma Trial in Houston (Temozolomide, Velban, Cisplatin)
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Cleveland (ascorbic acid, arsenic trioxide, dexamethasone)
Completed
- Chronic Myeloproliferative Disorders
- +3 more
- ascorbic acid
- +3 more
-
Cleveland, Ohio
- +1 more
Jul 23, 2020
Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)
Active, not recruiting
- Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +5 more
-
Mobile, Alabama
- +392 more
Jan 25, 2023
Multiple Myeloma and Plasma Cell Tumor Trial in Canada (prednisone, thalidomide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- prednisone
- thalidomide
-
Calgary, Alberta, Canada
- +17 more
Sep 11, 2020
COVID-19 Thalidomide Trial (, Thalidomide)
Unknown status
- COVID-19 Thalidomide
- placebo
- Thalidomide
- (no location specified)
Feb 19, 2020
COVID-19 Thalidomide Trial (thalidomide, )
Unknown status
- COVID-19 Thalidomide
- thalidomide
- placebo
- (no location specified)
Feb 19, 2020
Diffuse Large B-cell Lymphoma Trial in ZhengZhou (Chidamide, Vinorelbine, Liposomal Doxorubicin or mitoxantrone)
Unknown status
- Diffuse Large B-cell Lymphoma
- Chidamide
- +4 more
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 31, 2020
Multiple Myeloma Trial in Singapore (Bortezomib, Cyclophosphamide, Dexamethasone)
Unknown status
- Multiple Myeloma
- Bortezomib
- +4 more
-
Singapore, SingaporeNational University Hospital
Jan 23, 2020
Radiation Injuries Trial in Guangzhou, Guanzhou (Thalidomide)
Unknown status
- Radiation Injuries
- Thalidomide
-
Guangzhou, Guangdong, China
- +2 more
Nov 21, 2019
Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, New York (oblimersen sodium, dexamethasone, thalidomide)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- oblimersen sodium
- +2 more
-
Baltimore, Maryland
- +1 more
Oct 15, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in Philadelphia (Laboratory Biomarker Analysis, Thalidomide)
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
- Laboratory Biomarker Analysis
- Thalidomide
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Thalidomide, Laboratory Biomarker
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Corpus Leiomyosarcoma
- Thalidomide
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Multiple Myeloma Trial in United States (procedure, drug, behavioral)
Completed
- Multiple Myeloma
- One Autologous Transplant
- +5 more
-
Birmingham, Alabama
- +35 more
Oct 19, 2021
Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (tamoxifen
Completed
- Fallopian Tube Cancer
- +4 more
- tamoxifen citrate
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019